tiprankstipranks
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
US Market
LBRX
LB Pharmaceuticals, Inc.
RESEARCH TOOLSreports

LB Pharmaceuticals, Inc. (LBRX) Income Statement

42 Followers

LB Pharmaceuticals, Inc. Income Statement

Last quarter (Q4 2025), LB Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, LB Pharmaceuticals, Inc.'s net income was $-11.47M. See LB Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -321.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 30.08M$ 64.83M$ 11.38M$ 2.81M
Depreciation and Amortization
$ 321.00K$ 91.00K$ 4.00K$ 2.00K
EBITDA
$ -30.08M$ -63.01M$ -1.45M$ -12.19M
Operating Income
$ -30.40M$ -64.83M$ -11.38M$ -2.81M
Other Income/Expenses
$ 5.20M$ 1.73M$ 5.10M$ -11.54M
Pretax Income
$ -25.20M$ -63.10M$ -6.27M$ -14.35M
Net Income
$ -25.20M$ -63.10M$ -6.28M$ -14.35M
Per Share Metrics
Basic EPS
$ -1.00$ -17.83$ -1.77$ -4.05
Diluted EPS
$ -1.00$ -17.83$ -1.77$ -4.05
Weighted Average Shares Outstanding
 25.30M 3.54M 3.54M 3.54M
Weighted Average Shares Outstanding (Diluted)
 25.30M 3.54M 3.54M 3.54M
Currency in USD

LB Pharmaceuticals, Inc. Earnings and Revenue History